clonazepam and rivastigmine

clonazepam has been researched along with rivastigmine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Schenck, CH; Yeh, PY; Yeh, SB1
Avidan, AY; Carandang, G; During, EH; Foldvary-Schaefer, N; Howell, M; Kazmi, U; Malkani, RG; McCarter, SJ; Ramar, K; Roland, JP; Zak, RS1

Reviews

2 review(s) available for clonazepam and rivastigmine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2023, 04-01, Volume: 19, Issue:4

    Topics: Adult; Clonazepam; Humans; Melatonin; REM Sleep Behavior Disorder; Rivastigmine; Sleep; United States

2023

Other Studies

3 other study(ies) available for clonazepam and rivastigmine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer's disease.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010, Apr-15, Volume: 6, Issue:2

    Topics: Aged, 80 and over; Alzheimer Disease; Anticonvulsants; Cholinesterase Inhibitors; Clonazepam; Dose-Response Relationship, Drug; Humans; Male; Phenylcarbamates; Polysomnography; REM Sleep Behavior Disorder; Rivastigmine; Taiwan; Treatment Outcome

2010